These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2506661)

  • 41. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
    IMS Study Investigators
    Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasminogen, alpha 2-antiplasmin, and protein C decline following infusions of recombinant tissue plasminogen activator.
    Yang G; Green D
    Semin Thromb Hemost; 1990 Jul; 16(3):242-4. PubMed ID: 2122522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fibrinolytic therapy of deep leg- and pelvic vein thrombosis with various dosages of rt-PA--a pilot study].
    Doder A; Pilger E; Obernosterer A; Decrinis M; Tischler R; Lafer M; Stark G; Aschauer M
    Vasa Suppl; 1992; 37():41-2. PubMed ID: 1481095
    [No Abstract]   [Full Text] [Related]  

  • 44. Thrombolysis with intravenous human recombinant tissue-type plasminogen activator in acute myocardial infarction: the European experience.
    de Bono DP
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):75B-78B. PubMed ID: 2959717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beneficial effect of nitroglycerin on arterial rethrombosis after thrombolysis. Results from a rabbit thrombosis model.
    Kornowski R; Chernine A; Hasdai D; Ovadia Z; Battler A
    Eur Heart J; 1995 Feb; 16(2):177-83. PubMed ID: 7744088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina.
    Chaudhary H; Crozier I; Hamer A; Foy S; Shirlaw T; Ikram H
    Am J Cardiol; 1992 Jan; 69(3):173-5. PubMed ID: 1731454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
    Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
    Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate.
    Verstraete M; Arnold AE; Brower RW; Collen D; de Bono DP; De Zwaan C; Erbel R; Hillis WS; Lennane RJ; Lubsen J
    Am J Cardiol; 1987 Aug; 60(4):231-7. PubMed ID: 3113222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low molecular weight heparin (Fragmin) prevents early reocclusion following femoral artery thrombolysis with rt-PA in rabbits.
    Kornowski R; Glikson M; Hasdai D; Chernine A; Ohad D; Battler A
    Eur Heart J; 1994 Apr; 15(4):541-6. PubMed ID: 8070483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
    Schranz D; Haugwitz D; Zimmer B; Schumacher R
    Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bolus thrombolysis in venous thromboembolism.
    Agnelli G; Parise P
    Chest; 1992 Apr; 101(4 Suppl):172S-182S. PubMed ID: 1555482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo].
    Charbonnier B; Bernadet P; Schiele F; Thery C; Baudouy M; Bauters C
    Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1471-7. PubMed ID: 1297297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Interventional Management of Stroke (IMS) II Study.
    IMS II Trial Investigators
    Stroke; 2007 Jul; 38(7):2127-35. PubMed ID: 17525387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
    J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy and safety of recombinant tissue plasminogen activator infusion in acute myocardial infarction.
    Wang SP; Liu CP; Charng MJ; Chou CY; Tsai JH; Pan JP; Shyong WC; Chan WL; Kong CW; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Apr; 43(4):223-8. PubMed ID: 2509051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study].
    Aiach M; Fiessinger JN; Vitoux JF; Derlon A; Grollier G; Le Querrec A; Gouault-Heilmann M; Huet Y; Franco A; Polack B; Pouzol P; Dubois A; Schved JF; Boneu B; Guittard J; Sie P; Heilmann JJ; Kher A; Haye I
    Rev Med Interne; 1989; 10(4):375-81. PubMed ID: 2552552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.